Psychotic disorders among inpatients with abuse of cannabis, amphetamine and opiates. Do dopaminergic stimulants facilitate psychiatric illness?

European Psychiatry

Volumn 14, Issue 7, 1999, Pages 366-371

  Dalmau, A ^a   Bergman, B ^a   Brismar, B ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Amphetamine; Cannabis; Opiates; Psychiatric morbidity

Indexed keywords

AMPHETAMINE; OPIATE;

ALCOHOLISM; ARTICLE; CANNABIS ADDICTION; COMORBIDITY; DISEASE ASSOCIATION; DRUG MISUSE; HUMAN; MAJOR CLINICAL STUDY; MENTAL DISEASE; OPIATE ADDICTION; PRIORITY JOURNAL;

EID: 0032707197     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-9338(99)00234-5     Document Type: Article

References (32)

1. Abbott P.J., Weller S.B., Walker S.R. Psychiatric disorders of opioid addicts entering treatment: preliminary data. Magura S, Rosenblum A. Experimental Therapeutics in Addiction Medicine. 1994;1-11 The Haworth Press.
2. Allebeck P., Adamsson C., Engström A., Rydberg U. Cannabis and schizophrenia - A longitudinal study of cases treated in Stockholm County. Acta Psychiatr Scand. 88:1993;21-24.
3. Andréasson S., Allebeck P., Engström A., Rydberg U. Cannabis and schizophrenia- A longitudinal study of Swedish conscripts. Lancet. 26:1987;1483-1486.
4. Andréasson S., Allebeck P., Rydberg U. Schizophrenia in users and non-users of cannabis. Acta Psychiatr Scand. 79:1989;505-510.
5. Angrist B.M., Gershon S. The phenomenology of experimentally induced amphetamine psychosis-preliminary observations. Biol Psychiatry. 2:1970;95-107.
6. Baberg H.T., Nelesen R.A., Dimsdale J.E. Amphetamine use: return of an old scourge in a consultation psychiatry setting. Am J Psychiatry. 153:1996;789-793.
7. Brooner R.K., King V.L., Kidorf M., Schmidt C.W., Bigelow G.E. Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Arch Gen Psychiatry. 54:1997;71-80.
8. . Alcohol and narkotikaanvändandet i Sverige (The use of alcohol and drugs in Sweden). Report No. 6. Stockholm. 1998.
9. Cohen M., Klein D.F., Oaks G. Age of onset of drug abuse in psychiatric inpatients. Arch Gen Psychiatry. 26:1972;266-269.
10. Dixon L., Haas G., Weiden P.J., Sweeney J., Frances A.J. Drug abuse in schizophrenic patients: clinical correlates and reasons for use. Am J Psychiatry. 148:1991;224-230.
11. Griffith J.D., Fann W.E., Oates J.A. The amphetamine psychosis: experimental manifestations. Ellinwood E.H, Cohen S. Current concepts on amphetamine abuse. 1972;185-191 Rockville Maryland National Institute of Mental Health: DHEW Publication.
12. Hechtman L. Adolescent outcome of hyperactive children treated with stimulants in childhood: A review. Psychopharmacol Bull. 21:1985;178-191.
13. Helling S. Droger utan gräns. (Drugs without border). 1985;92-102 Stockholm: P A Norstedt & Söners förlag.
14. Helling S. Världens droger, Världens fakta nr 13, Utrikespolitiska Institutet. (The drugs of the world, The fact of the world No 13, The Institute of Foreign Affairs). 1993;13 Stockholm: Tierps Tryckeri AB.
15. Jansson B. Ungdomsnarkomanin i Sverige. (Narcotic addiction among youngsters in Sweden). Nordisk psykiatrisk tidskrift. 24:1970;44-56.
16. Kessler R.C., Nelson C.B., McGonagle K.A., Edlund M.J., Frank R.G., Leaf P.J. The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization. Am J Orthopsychiatry. 66:1996;17-31.
17. Khantzian E.J., Treece C. DSM-III psychiatric diagnosis of narcotic addicts. Arch Gen Psychiatry. 42:1985;1067-1071.
18. Kokkevi A., Stefanis C. Drug abuse and psychiatric comorbidity. Compr Psychiatry. 36:1995;329-337.
19. Konuma K. Use and abuse of amphetamines in Japan. Cho A.K, Segal D.S. Amphetamine and Its Analogs. 1994;415-435 San Diego: Academic Press Inc.
20. Kuczenski R., Segal D.S. Neurochemistry of amphetamine. Cho A.K, Segal D.S. Amphetamine and Its Analogs. 1994;81-104 San Diego: Academic Press Inc.
21. McLelland A.T., Woody G.E., O'Brian C.P. Development of psychiatric illness in drug abusers. The N Engl J M. 301:1979;1310-1314.
22. Miller M.A., Hughes A.L. Epidemiology of amphetamine use in the United States. Cho A.K, Segal D.S. Amphetamine and Its Analogs. 1994;439-457 San Diego: Academic Press Inc.
23. Negrete J.C., Knapp W.P., Douglas D.E., Smith W.B. Cannabis affects the severity of schizophrenic symptoms: results of a clinical survey. Psychol M. 16:1986;515-520.
24. Regier D.A., Farmer M.E., Rae D.S., Locke B.Z., Keith S.J., Judd L.L., et al. Comorbidity of mental disorders with alcohol and other drug abuse. JAMA. 264:1990;2511-2518.
25. Rounsaville B.J., Weissman M.M., Kleber H., Wilber C. Heterogeneity of psychiatric diagnosis in treated opiate addicts. Arch Gen Psychiatry. 39:1982;161-166.
26. Ross H.E., Glaser F.B., Germanson T. The prevalence of psychiatric disorders in patients with alcohol and other drug problems. Arch Gen Psychiatry. 45:1988;1023-1031.
27. Russell J.M., Newman S.C., Bland R.C. Drug abuse and dependence. Acta Psychiatr Scand. Suppl 376:1994;54-62.
28. 1968;Stockholm: Liber Distribution.
29. 1987;Stockholm: Nordstedts Tryckeri.
30. Schneier F.R., Siris S.G. A review of psychoactive substance use and abuse in schizophrenia. J Nerv Ment Dis. 175:1987;641-652.
31. Shaffer D. Attention deficit hyperactivity disorder in adults. Am J Psychiatry. 151:1994;633-638.
32. Treffert D.A. Marijuana use in schizophrenia: a clear hazard. Am J Psychiatry. 135:1978;1213-1215.